Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04273672 · ClinicalTrials.gov registry record
Speech, Linguistic and Acoustic Markers in Parkinson's Disease
A clinical trial of Parkinson Disease and Speech, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- 58
- Enrollment target
- 1
- Study location
NCT04273672 is a study of Parkinson Disease and Speech that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 58 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04273672, a study of Parkinson Disease and Speech, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- 58 participants
- Enrollment target
- 1
- Study location
Study Summary
The Investigators aim to identify speech and language markers that provide information on cognitive function and predict cognitive decline in Parkinson's disease. The Investigators will administer speech tasks and cognitive assessments to participants with Parkinson's disease and healthy controls. The Investigators will also explore the associations between genetic factors and speech and cognitive status in Parkinson's disease.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Cognitive Battery
- BEHAVIORAL Voice, Speech and Language Analysis
- BEHAVIORAL Questionnaires and Clinical Assessments
- GENETIC DNA Analysis
Study Locations (1)
Massachusetts
- UMass Medical School/UMass Memorial Medical Center - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2020-01-13 |
| Est. Completion | 2025-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04273672
The ClinicalTrials.gov registry entry for NCT04273672 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 4 interventions - of which Cognitive Battery is the first listed.
NCT04273672 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04273672 about?
NCT04273672 is a clinical study titled "Speech, Linguistic and Acoustic Markers in Parkinson's Disease". The Investigators aim to identify speech and language markers that provide information on cognitive function and predict cognitive decline in Parkinson's disease. The Investigators will administer speech tasks and cognitive assessments to participants with Parkinson's disease and healthy controls. T...
What is the current status of trial NCT04273672?
This trial is currently completed. The enrollment target is 58 participants. The study started on 2020-01-13. Estimated completion is 2025-02-28.
What conditions does trial NCT04273672 study?
This clinical trial studies the following conditions: Parkinson Disease, Speech, Cognitive Impairment, Mild.
What interventions are being tested in trial NCT04273672?
The interventions under investigation include: Cognitive Battery (DIAGNOSTIC_TEST), Voice, Speech and Language Analysis (BEHAVIORAL), Questionnaires and Clinical Assessments (BEHAVIORAL), DNA Analysis (GENETIC).
Who is sponsoring clinical trial NCT04273672?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04273672 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
RECRUITING
-
University of Delaware Parkinson's Disease Registry
RECRUITING
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.